Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis

Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis

10.1002/ehf2.13822

Saved in:

Bibliographic Details
Main Authors:	Yeong, Trevor, Mai, Aaron Shengting, Lim, Oliver ZH, Ng, Cheng Han, Chin, Yip Han, Tay, Phoebe, Lin, Chaoxing, Muthiah, Mark, Khoo, Chin Meng, Dalakoti, Mayank, Loh, Poay-Huan, Chan, Mark, Yeo, Tiong-Cheng, Foo, Roger, Wong, Raymond, Chew, Nicholas WS, Lin, Weiqin
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	WILEY PERIODICALS, INC 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Heart failure Sodium-glucose cotransporter 2 inhibitors Glucagon-like peptide 1 receptor agonists Metformin GLP-1 RECEPTOR AGONISTS CARDIOVASCULAR OUTCOMES EJECTION FRACTION SGLT2 INHIBITORS MORTALITY LIRAGLUTIDE EMPAGLIFLOZIN HOSPITALIZATION DISEASE DEATH
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/219418
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1002/ehf2.13822